1. Home
  2. MAIA vs JG Comparison

MAIA vs JG Comparison

Compare MAIA & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • JG
  • Stock Information
  • Founded
  • MAIA 2018
  • JG 2012
  • Country
  • MAIA United States
  • JG China
  • Employees
  • MAIA N/A
  • JG 393
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • JG Computer Software: Programming Data Processing
  • Sector
  • MAIA Health Care
  • JG Technology
  • Exchange
  • MAIA Nasdaq
  • JG Nasdaq
  • Market Cap
  • MAIA 46.7M
  • JG 52.8M
  • IPO Year
  • MAIA 2022
  • JG 2018
  • Fundamental
  • Price
  • MAIA $2.03
  • JG $9.05
  • Analyst Decision
  • MAIA
  • JG
  • Analyst Count
  • MAIA 0
  • JG 0
  • Target Price
  • MAIA N/A
  • JG N/A
  • AVG Volume (30 Days)
  • MAIA 319.8K
  • JG 14.1K
  • Earning Date
  • MAIA 05-20-2025
  • JG 06-05-2025
  • Dividend Yield
  • MAIA N/A
  • JG N/A
  • EPS Growth
  • MAIA N/A
  • JG N/A
  • EPS
  • MAIA N/A
  • JG N/A
  • Revenue
  • MAIA N/A
  • JG $43,316,299.00
  • Revenue This Year
  • MAIA N/A
  • JG $10.90
  • Revenue Next Year
  • MAIA N/A
  • JG N/A
  • P/E Ratio
  • MAIA N/A
  • JG N/A
  • Revenue Growth
  • MAIA N/A
  • JG 8.94
  • 52 Week Low
  • MAIA $1.40
  • JG $2.36
  • 52 Week High
  • MAIA $5.99
  • JG $20.94
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 53.91
  • JG 48.85
  • Support Level
  • MAIA $1.80
  • JG $8.45
  • Resistance Level
  • MAIA $2.18
  • JG $9.35
  • Average True Range (ATR)
  • MAIA 0.30
  • JG 0.33
  • MACD
  • MAIA -0.01
  • JG 0.10
  • Stochastic Oscillator
  • MAIA 30.29
  • JG 58.06

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

Share on Social Networks: